The stock price of Adlai Nortye Ltd. (trading under the NASDAQ ticker symbol ANL) fluctuates continuously during active market trading sessions based on real-time supply and demand forces. Recent financial market data and stock exchange quotes position the share price in the mid-teens range, specifically hovering around $13.79 per share. As a clinical-stage biopharmaceutical enterprise focused on discovering and developing innovative cancer immunotherapy treatments, its equity valuation is highly sensitive to clinical trial outcomes, regulatory milestones, biotechnology sector sentiment, and quarterly research expenditure updates. Investors tracking the ticker must review live feeds directly through authorized financial platforms or brokerage applications during market hours, as daily trading ranges, volume shifts, and broader market volatility can cause rapid intraday price movements.